Metric Finance
LearnFAQ
LearnFAQ

Learn / LMRI

NASDAQ: LMRI

Lumexa Imaging Holdings (LMRI) stock, explained like you're 5

Lumexa Imaging Holdings trades on the Nasdaq under the ticker LMRI. It is a small cap company in the medical specialities industry, part of the healthcare sector, with a market value of about 1 billion dollars.

Ticker
LMRI
Exchange
Nasdaq
Sector
Healthcare
Industry
Medical Specialities
Size
Small cap, about 1 billion dollars

Is Lumexa Imaging Holdings a small, medium or large cap company?

No. Lumexa Imaging Holdings is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Lumexa Imaging Holdings makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves LMRI stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Lumexa Imaging Holdings (LMRI) Could Be 36% Below Fair Value On Its Imaging Growth Story (Yahoo Finance)
  • Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) Could Be Less Than A Year Away From Profitability (Simply Wall Street)
  • symbol__ Stock Quote Price and Forecast (CNN)
  • LUMEXA IMAGING HOLDINGS ($LMRI) Releases Q2 2026 Earnings, Stock Rises (Quiver Quantitative)
  • Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) Receives Average Recommendation of "Buy" from Analysts (MarketBeat)

Follow LMRI in your daily brief

Each trading day at 5 PM ET we post what happened to Lumexa Imaging Holdings and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow LMRI

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Lumexa Imaging Holdings stock

What does Lumexa Imaging Holdings do?

Lumexa Imaging Holdings trades on the Nasdaq under the ticker LMRI. It is a small cap company in the medical specialities industry, part of the healthcare sector, with a market value of about 1 billion dollars.

What is the ticker symbol for Lumexa Imaging Holdings?

Lumexa Imaging Holdings trades under the ticker LMRI on the Nasdaq.

What is Lumexa Imaging Holdings's market cap?

Lumexa Imaging Holdings is a small cap stock with a market cap of about 1 billion dollars.

How does Lumexa Imaging Holdings make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves LMRI stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow LMRI stock every day?

Add LMRI to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow LMRI daily

A free brief on Lumexa Imaging Holdings and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • UNH · Unitedhealth Group
  • NTRA · Natera
  • ILMN · Illumina
  • CNC · Centene

Similar stocks

  • UNHUnitedhealth Group
  • NTRANatera
  • ILMNIllumina
  • CNCCentene

Compare LMRI: LMRI vs UNH, LMRI vs NTRA, LMRI vs ILMN

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed